2024 ASM Posters

 

 

ENVIRONMENTAL SUSTAINABILITY

 
POSTER # POSTER TITLE PRESENTING AUTHOR
01 AUDIT OF HAEMODIALYSIS ADEQUACY TO PROVIDE MORE PERSONALISED AND GREEN NEPHROLOGY CARE Mitchell Hunter-Dickson
02 CURRENT WATER CONSERVATION METHODS IN CLINICAL HEMODIALYSIS: A SCOPING REVIEW Arnie Sen, Kiren Bhatia

GENERAL NEPHROLOGY – ACUTE KIDNEY INJURY

03 SOMETHING IS BREWING Kate Brotherton
04 IMMUNE CHECK POINT INHIBITOR AND ANTHRACYCLINE INDUCED ATYPICAL HAEMOLYTIC URAEMIC SYNDROME Katrina Chau
05 INCIDENCE AND OUTCOMES OF ACUTE KIDNEY INJURY IN ADMITTED INPATIENTS. Mary Kee Whye Chin
06 RELIANCE ON CREATININE AFTER CARDIAC SURGERY FAILS TO IDENTIFY ACUTE KIDNEY INJURY (AKI): THE NEED FOR URINE OUTPUT AND URINE BIOMARKERS Camila Eleuterio Rodrigues
07 SHORT- & LONG-TERM MORTALITY AFTER AN AKI IN NON-CRITICAL SETTING Camila Eleuterio Rodrigues
08 LONG TERM SAFE REINTRODUCTION OF WARFARIN THERAPY FOLLOWING ANTICOAGULANT RELATED NEPHROPATHY : A CASE REPORT Caitlin Cocks, Mohd Azlan Mohd Hashim
09 ACUTE KIDNEY INJURY IN ACUTE MYELOMONOCYTIC LEUKAEMIA (AMML):THERE IS MORE TO THIS THAN MEETS THE EYE Human Hazim
10 A CASE OF CHRONIC MYELOMONOCYTIC RELATED LYSOZYME-INDUCED NEPHROPATHY Abhik Kansal
11 CASE REPORT: FIRST PRESENTATION OF G6PD DEFICIENCY IN AN ELDERLY PATIENT WITH SEVERE HAEMOLYSIS, ACUTE KIDNEY INJURY AND METHAEMOGLOBINAEMIA Peter-joon Lee
12 TYROSINE KINASE INHIBITOR AND MASSIVE PROTEINURIA Patrick Manley
13 THE WISDOM IN A TOOTH: A POSSIBLE PRECIPITANT FOR POST-STREPTOCOCCAL GLOMERULONEPHRITIS Catherine Mao
14 REVIEW OF AKI MANAGEMENT IN HOSPITALISED PATIENTS REFERRED FOR NEPHROLOGY CONSULT Sophie O’Brien
15 PRACTICE PATTERNS AND PREDICTORS OF NET ULTRAFILTRATION RATE IN INTERMITTENT HAEMODIALYSIS FOR ACUTE KIDNEY INJURY: A SINGLE-CENTRE RETROSPECTIVE OBSERVATIONAL STUDY Lisa Paxton
16 A CASE OF RENAL-LIMITED THROMBOTIC MICROANGIOPATHY WITH COLLAPSING GLOMERULOPATHY IN A PATIENT TAKING UNLABELLED BODYBUILDING SUPPLEMENTS Harsha Suresh
17 MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR RELATED ACUTE KIDNEY INJURY: A LOCAL CLINICAL PRACTICE GUIDELINE Muh Geot Wong

GENERAL NEPHROLOGY – DIABETES/CARDIOVASCULAR/HYPERTENSION

18 A CASE SERIES OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR USE IN TYPE 1 DIABETES IN A RURAL SETTING. Stephanie Drake
19 SCOPING REVIEW OF BLOOD PRESURE OUTCOMES FOLLOWING ATTENDANCE AT SPECIALIST HYPERTENSION CLINICS Arunima Jain
20 EXPLORING THE GUT-KIDNEY-AXIS IN A MOUSE MODEL OF DIABETIC KIDNEY DISEASE Amalia S. Khayyira
21 PHASE II DOSE-SELECTION, RANDOMIZED, CONTROLLED TRIAL OF ASI BI 690517 WITH AND WITHOUT EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE: SUBGROUP ANALYSIS BY TYPE 2 DIABETES STATUS Morag Nelson
22 STRATEGIES TO IMPROVE EVIDENCE-BASED CARE DELIVERY IN TYPE 2 DIABETES MELLITUS ACCORDING TO PATIENTS AND MULTIDISCIPLINARY CLINICIANS Daniel O’Hara
23 A CASE OF PREGABALIN INDUCED HYPOGLYCAEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM) Salonee Phanse
24 KIDNEY-BONE RESPONSE MODULATES THE EFFECT OF SKELETAL VDR/RXR ON FGF23 SECRETION IN DB/DB MICE Wenjing Wu

GENERAL NEPHROLOGY – EPIDEMIOLOGY & PUBLIC HEALTH

25 THE AUSTRALIAN TELETRIAL PROGRAM – AT LAST  A SERIOUS AND UNIQUE PROGRAM INCREASING EQUITY IN RESEARCH IN AUSTRALIA Pascale Dettwiller
26 ALBUMINURIA, KIDNEY FUNCTION AND HEART FAILURE IN TYPE 2 DIABETES: A SECONDARY ANALYSIS FROM THE CANVAS PROGRAM AND CREDENCE TRIAL Jeffrey Ha
27 EPIDEMIOLOGY OF RENAL INFARCT: INCIDENCE AND RISK OF MORTALITY AND KIDNEY FAILURE IN AN AUSTRALIAN LOCAL HEALTH DISTRICT Kelly Lambert
28 SARS-COV-2 ADJACENT HOSPITALISATION IN PATIENTS WITH END STAGE KIDNEY DISEASE IN SOUTH AUCKLAND Shaheen Patel
29 PATIENT PREFERENCES FOR INTERVENTIONS AND SERVICES TO IMPROVE SOCIAL CONNECTIONS IN CKD: AN INTERVIEW STUDY Amanda Sluiter
30 WATER EVERYWHERE AND NOT A DROP TO DRINK – DISASTER MANAGEMENT IN FAR NORTH QUEENSLAND Catherine Wilkinson

GENERAL NEPHROLOGY – GLOMERULONEPHRITIS

31 A RARE PRESENTATION OF CONCURRENT ANTI-GBM DISEASE AND IGA NEPHROPATHY: A CASE REPORT Bryony Beal
32 OUTCOMES OF PRIMARY MEMBRANOUS NEPHROPATHY REFRACTORY TO IMMUNOSUPPRESSANTS: A SYSTEMATIC REVIEW Bhadran Bose
33 SILICOSIS AND ITS ASSOCIATION WITH AUTOIMMUNITY: THREE CASES SILICOSIS-RELATED ANCA VASCULITIS Cameron Burnett
34 ANCA-ASSOCIATED VASCULITIS WITH ISOLATED C3 IMMUNOFLUORESCENCE AND ELECTRON-DENSE DEPOSITS: A CASE REPORT Craig Coorey
35 CLASS V LUPUS NEPHRITIS COMPLICATED BY MULTIPLE BONE INFARCTIONS: A CASE REPORT Craig Coorey
36 TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS (TINU) UNRESPONSIVE TO CORTICOSTEROIDS AND MYCOPHENOLATE MOFETIL Shyamalee Crocker
37 SECONDARY FOCAL SCLEROSING GLOMERULOSCLEROSIS ASSOCIATED WITH CONGENITAL HEPATIC FIBROSIS Shyamalee Crocker
38 STRUCK BY KIDNEY DISEASE Stephanie Lam
39 AN AUSTRALIAN RURAL CASE STUDY OF OVERLAP SYNDROME BETWEEN ATYPICAL ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE AND MEMBRANOUS NEPHROPATHY Joshua Lee
40 FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS AFTER ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS IN A PATIENT WITH LOW RESTING CD4+CD25+CD127lo T REGULATORY CELLS Tracy Li
41 PICKING A HOLE IN THE NOSE: NASOPALATAL OSTEOMYELITIS IN ANCA-VASCULITIS Tracy Li
42 DEVELOPMENT OF MEMBRANOUS NEPHROPATHY AFTER TREATMENT FOR ANCA-POSITIVE VASCULITIS – A CASE SERIES Rhea Navani
43 A PAIN IN THE GUT: IGA VASCULITIS WITH BOWEL INVOLVEMENT Felicity Sartain
44 OBINUTUZUMAB FOR TREATMENT-RESISTANT MEMBRANOUS NEPHROPATHY: A SINGLE CENTRE EXPERIENCE Krita Sridharan
45 INCIDENCE AND TREATMENT OUTCOMES OF LUPUS NEPHRITIS IN FIJI Anis Ta’eed
46 PARTIAL RENAL RECOVERY IN AN ADULT PATIENT WITH C3 GLOMERULONEPHRITIS TREATED WITH MYCOPHENOLATE MOFETIL AND PREDNISOLONE Zaw Thet
47 FALSE POSITIVE ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY IN A PATIENT PRESENTING WITH MENINGOENCEPHALITIS Aisha Yaseen

GENERAL NEPHROLOGY – HEALTH SERVICES RESEARCH

48 ONE-YEAR EVALUATION OF THE METRO NORTH HEALTH, BRISBANE ADOLESCENT AND YOUNG ADULT KIDNEY CLINIC Brian Doucet
49 ENHANCING PATIENTS’ KNOWLEDGE THROUGH VIDEO-ASSISTED CONSENT FOR KIDNEY BIOPSIES (ECONSENT BX): A RANDOMISED CONTROLLED TRIAL Julia Jefferis
50 DEVELOPMENT AND IMPLEMENTATION OF THE METRO NORTH HEALTH, BRISBANE ADOLESCENT AND YOUNG ADULT KIDNEY CLINIC Nicharee Sangdurn
51 EXPLORING KIDNEY BIOPSY COMPLICATIONS: UNDERSTANDING RISK FACTORS AND HISTOLOGICAL CORRELATIONS Sandhya Srinivasan
52 DEVELOPMENT OF CRITERIA LED DISCHARGE FOR UNCOMPLICATED KIDNEY AND URINARY TRACT INFECTIONS: A QUALITY ASSURANCE STUDY OF ADMISSIONS AT CONCORD HOSPITAL OVER A 12 MONTH PERIOD Thiveya Theivendran
53 IMPACT OF TRAVEL TIME ON DIALYSIS MODALITY IN AOTEAROA NEW ZEALAND Angela Webster

GENERAL NEPHROLOGY – OTHER

54 WHY ARE PATIENTS WITH IGA NEPHROPATHY NOT ON SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS – A SINGLE CENTRE RETROSPECTIVE REAL-WORLD STUDY Mohammad Alamein
55 LONG-TERM EXPERIENCES OF INCREASING WATER INTAKE IN PEOPLE WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Sneha Amin
56 KIDNEY OUTCOMES OF TOXIC ALCOHOL POISONING IN NEW SOUTH WALES: A RETROSPECTIVE STUDY Jessie Beaulieu
57 RISK FACTORS AND CLINICAL OUTCOMES OF HYPONATREMIA IN COVID-19 PATIENTS ADMITTED AT A TERTIARY HOSPITAL FROM JANUARY 1, 2021 TO DECEMBER 31, 2021: A CASE-CONTROL STUDY Brian Michael  Cabral
58 THALASSAEMIA NEPHROPATHY STUDY Sarah Cameron
59 COMMUNICATION WORKSHOPS IN NEPHROLOGY – THE AUSTRALIAN EXPERIENCE Jenny Chen
60 CULTURED PROXIMAL TUBULAR CELLS SHOW NANOPLASTIC UPTAKE AND IMPAIRMENTS IN GROWTH AND CELL CYCLE Hayden Gillings
61 TIME-LIMITED TRIAL OF DIALYSIS: AN AUSTRALIAN AND NEW ZEALAND PERSPECTIVE Kirsten Hepburn
62 ESTABLISHING A CORE OUTCOME FOR LIFE PARTICIPATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT REQUIRING KIDNEY REPLACEMENT THERAPY: A STANDARDISED OUTCOMES IN NEPHROLOGY – CHRONIC KIDNEY DISEASE (SONG-CKD) CONSENSUS WORKSHOP REPORT Anastasia Hughes, Andrea Matus-Gonzalez, Allison Jaure
63 DISSEMINATING RESEARCH IN CHRONIC KIDNEY DISEASE TO PATIENTS AND CAREGIVERS: A WORKSHOP REPORT Anastasia Hughes
64 TIME SPENT IN HOSPITAL: OLDER KIDNEY PATIENTS IN THE LAST 12 MONTHS OF LIFE Abdul Mueez Khalil
65 OLDER ADULTS FUNCTIONAL STATUS AND SYMPTOM BURDEN IN THE LAST 12MONTHS OF LIFE Abdul Mueez Khalil
66 A CASE OF MYELOPROLIFERATIVE NEOPLASM-RELATED GLOMERULOPATHY WITH RENAL EXTRAMEDULLARY HAEMATOPOIESIS Peter-joon Lee
67 ADHERENCE OF CHRONIC KIDNEY DISEASE PATIENTS TO SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) DURING RAMADAN PERIOD Fei Yee Lee
68 CHANGES IN KIDNEY BIOPSY PRACTICE AND DIAGNOSES OVER THE COURSE OF THE COVID-19 PANDEMIC Monica Suet Ying Ng
69 A CASE OF SEVERE BILATERAL EMPHYSEMATOUS PYELONEPHRITIS Samuel Pack
70 REPEAT BONE SCAN AS A METHOD OF MONITORING RESPONSE TO SODIUM THIOSULFATE IN CALCIPHYLAXIS – A CASE REPORT Evelyn Perry
71 CARI GUIDELINES FRAMEWORK FOR INCLUDING PEOPLE WITH LIVED EXPERIENCE OF KIDNEY DISEASE IN DEVELOPING CLINICAL PRACTICE GUIDELINES Ieyesha Roberts
72 “A GUT FEELING”: DETERMINING THE CAUSE OF A CASE OF AA AMYLOIDOSIS Felicity Sartain
73 KIDNEY SUPPORTIVE CARE – WHERE AND WHEN ARE OUR PATIENTS DYING? Lee Skeat
74 COMPARISON OF PATIENT SYMPTOM BURDEN BY DIALYSIS MODALITY – A SINGLE CENTRE ANALYSIS Lee Skeat
75 METFORMIN FOR PREVENTING THE PROGRESSION OF CHRONIC KIDNEY DISEASE: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS Isabelle Kitty Stanley
76 CARI GUIDELINES UPDATED RECOMMENDATIONS FOR THE MANAGEMENT OF KIDNEY STONES David Tunnicliffe
77 IMPACTS OF RESEARCH THAT ARE MEANINGFUL AND IMPORTANT TO PATIENTS LIVING WITH CHRONIC KIDNEY DISEASE AND THEIR CAREGIVERS Rebecca Wu
78 PATIENT AND CAREGIVER INVOLVEMENT IN IDENTIFYING AND DESIGNINIG INTERVENTIONS FOR RESEARCH IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW Rebecca Wu

GENERAL NEPHROLOGY – PREGNANCY ASSOCIATED

79 UTILITY OF RENAL BIOPSY IN PREGNANCY: A CASE REPORT Prudence Gregory
80 REFRACTORY HYPOKALAEMIA IN PREGNANCY: AN UNUSUAL PRESENTATION OF RENAL ARTERY STENOSIS Isra Iftikhar
81 ADEQUACY AND SAFETY OF RENAL BIOPSIES IN PREGNANCY – A CASE-CONTROL STUDY Soo Ying Ong

GENETICS

82 MODE OF PRESENTATION IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Saleh Alzahrani
83 PRIMARY COENZYME Q10 DEFICIENCY PRESENTS WITH NEPHROTIC SYNDROME IN ADULTHOOD DURING PREGNANCY: A CASE REPORT Cobi Fredric

HAEMODIALYSIS – CKD-MBD/ANAEMIA/ADEQUACY

84 CASE REPORT: ORAL PENTOXIFYLLINE, POTENTIALLY EFFECTIVE ADDITIONAL TREATMENT FOR CALCIPHYLAXIS Mohammad Alamein
85 TERITARY HYPERPARATHYROIDISM IN STAGE III CHRONIC KIDNEY DISEASE: THE NEED FOR PARATHYROIDECTOMY Lauren Heath
86 BROWN TUMOUR DEPOSITS IN THE CERVICAL SPINE Andrea Huang

HAEMODIALYSIS – OTHER

87 DIALYSIS TRAVEL DISTANCE AND MODALITY IN METROPOLITAN AND REGIONAL VICTORIA Katherine Downe
88 THE SUCCESSFUL USE OF MARIBAVIR FOR GANCICLOVIR RESISTANT CYTOMEGALOVIRUS DISEASE IN PERSON WITH KIDNEY FAILURE ON HAEMODIALYSIS Kanzool Hasan
89 INPATIENT REHABILITATION OUTCOMES IN HAEMODIALYSIS PATIENTS: AN ANALYSIS INTO MISSED THERAPY Abdul Mueez Khalil
90 HOME HAEMODIALYSIS TRAINING TIMES IN THE CONTEMPORARY ERA Rohan Khanal
91 EVALUATION OF BACTERIOLOGICAL QUALITIES OF DIALYSIS WATER IN HAEMODIALYSIS UNITS CARING FOR FIRST NATIONS PATIENTS WITH HIGH INFLAMMATORY MARKERS IN NORTHERN TERRITORY OF AUSTRALIA: AN INFERR CLINICAL TRIAL SUB STUDY Gathika Kodithuwakku
92 PERSPECTIVES OF SOCIAL HEALTH AND CONNECTIONS AMONG ARAB AUSTRALIANS RECEIVING KIDNEY REPLACEMENT THERAPY: AN INTERVIEW STUDY Karine Manera
93 PERIPHERAL EOSINOPHIL COUNT  AS RISK FACTOR OF ALL-CAUSE ONE-YEAR  MORTALITY IN HEMODIALYSIS PATIENTS; A RETROSPECTIVE COHORT STUDY FROM MEDAN, INDONESIA Riri Muzasti
94 OPERATIVE AND NON-OPERATIVE MANAGEMENT OF ACUTE CHOLECYSTITIS IN PATIENTS ON CHRONIC KIDNEY REPLACEMENT THERAPY Dharmenaan Palamuthusingam
95 IMPACT OF PROPHYLACTIC-DOSE ENOXAPARIN ANTICOAGULATION ON ANTI-Xa LEVELS, BLEEDING AND EXTRACORPOREAL CIRCUIT THROMBOSIS IN PATIENTS ON CHRONIC INTERMITTENT HAEMODIALYSIS Shaundeep Sen
96 IMPLEMENTATION OF INFORMED CONSENT FOR DIALYSIS – A SINGLE CENTRE EXPERIENCE Daniel O’Hara
97 TEMPORAL CHANGE IN ULTRAFILTRATION RATE IN HAEMODIALYSIS PATIENTS OVER A THREE-MONTH PERIOD Estelle Sultana
98 SIX-MONTH OUTCOMES OF CHRONIC HAEMODIALYSIS PATIENTS AT A TERTIARY NEPHROLOGY SERVICE IN PERTH, WESTERN AUSTRALIA Ben Tomlinson
99 PATHWAYS AND INDICATIONS OF CHRONIC HAEMODIALYSIS COMMENCEMENT IN A TERTIARY NEPHROLOGY CENTRE IN PERTH, WESTERN AUSTRALIA. Ben Tomlinson
100 PREVALENCE OF COGNITIVE IMPAIRMENT, REDUCED GRIP STRENGTH AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS FROM TWO SATELLITE HAEMODIALYSIS CENTRES IN INNER WESTERN SYDNEY: A PROSPECTIVE COHORT STUDY. Lucy Qiu-Yun Wang
101 ANASARCA AND PERICARDIAL EFFUSION ASSOCIATED WITH MINOXIDIL USE IN END STAGE KIDNEY DISEASE (ESKD) ON HAEMODIALYSIS Catherine Wilkinson

HAEMODIALYSIS – VASCULAR ACCESS

102 WHEN IS FISTULA FIRST A SECOND RATE OPTION FOR LONG TERM DIALYSIS ACCESS Neesan David
103 A CHANGE OF HEART: THE EFFECT OF HIGH FLOW ARTERIOVENOUS FISTULAS ON CARDIOVASCULAR OUTCOMES – A SYSTEMATIC REVIEW AND SYNTHESIS WITHOUT META-ANALYSIS (SWiM) Morgan Hind
104 IMPROVING MANAGEMENT OF NEEDLE DISTRESS DURING THE JOURNEY TO DIALYSIS THROUGH PSYCHOLOGICAL EDUCATION AND TRAINING (INJECT) – A PILOT FEASIBILITY STUDY Shilpanjali Jesudason
105 FISTULA THROMBOSIS IN A REGIONAL QUEENSLAND CENTRE Takuma Konno
106 ACUTE KIDNEY INJURY OUTCOMES IN PEOPLE WITH DIALYSIS CATHETERS – SECONDARY ANALYSIS FROM A NATIONAL TRIAL. Sradha Kotwal
107 CATHETER RELATED BLOODSTREAM INFECTION RATE AT THE FIJI NATIONAL KIDNEY CENTRE Abhitesh Raj
108 CARE PLAN ASSESSMENT FOR NEW ARTERIOVENOUS FISTULA IN DIALYSIS NURSING Yenty Yenty, Amanda Keen

INDIGENOUS ADVANCEMENT

109 HISTORICAL AND CONTEMPORARY BURDEN OF END STAGE KIDNEY DISEASE AMONG TORRES STRAIT ISLANDER PEOPLE OF  AUSTRALIA, 1963-2022 Jaqui Hughes
110 PLANNING FOR LOCALLY PROVIDED HAEMODIALYSIS CARE IN BADU ISLAND IN THE TORRES STRAIT: KIKIRRUI DAN WALMAI PROJECT Jaqui Hughes
111 IMPROVING PATIENT ENGAGEMENT AND QUALITY OF CARE FOR INDIGENOUS HAEMODIALYSIS PATIENTS THROUGH OUTREACH PROGRAM Archana Khadka Shapkota
112 RETURN TO COUNTRY: A PALLIATIVE EXPERIENCE IN FAR NORTH QUEENSLAND Matthew Paavola, Natalie Thaiday, Catherine Wilkinson

INTERVENTIONAL NEPHROLOGY

113 A RETROSPECTIVE ANALYSIS OF THE PERITONEAL DIALYSIS SALVAGE PROGRAM FOR NON AND MALFUNCTIONING PERITONEAL DIALYSIS CATHETERS Luke Armour
114 NON BREATH  HOLD ULTRASOUND GUIDED RENAL BIOPSY : REVIEW OF TECHNIQUE, CLINICAL AND HISTOPATHOLOGICAL OUTCOME Ferdinand Chu
115 ENDOVASCULAR MANAGEMENT OF AN ASYMPTOMATIC INCIDENTAL NONRUPTURED GIANT RENAL ARTERY ANEURYSM IN PREGNANCY Pooja Krishnaswamy

NUTRITION

116 INTRADIALYTIC PARENTERAL NUTRITON (IDPN) – DO WE PRACTICE WHAT WE PREACH? Anthony Meade

PAEDIATRICS

117 EPIDEMIOLOGY OF STEROID SPARING AGENTS IN CHILDHOOD NEPHROTIC SYNDROME Chad Maidment
118 MANAGEMENT OF PAEDIATRIC IGA VASCULITIS WITH NEPHRITIS: A SINGLE-CENTRE EXPERIENCE Thomas Miller
119 PATIENT AND CAREGIVER PERSPECTIVES ON MENTAL HEALTH IN CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE Luca Gaetano Torrisi

PERITONEAL DIALYSIS

120 CHARACTERISTICS OF PERITONEAL DIALYSIS-RELATED PERITONITIS DURING THE COVID-19 PANDEMIC Jessica Davies
121 A 10 YEAR ANZDATA ANALYSIS OF PERITONEAL DIALYSIS TECHNIQUE SURVIVAL Jarrad Hopkins
122 PERITONEAL DIALYSIS WITH LEFT VENTRICULAR ASSIST DEVICE: A CASE STUDY Andrea Huang
123 ANTICOAGULATION USE IN PERITONEAL DIALYSIS PATIENTS WITHIN THE WESTERN RENAL SERVICE Sumedh Jayanti
124 HYPOKALAEMIA AND PERITONEAL DIALYSIS- RELATED PERITONITIS: ASSOCIATION, RISK FACTORS AND OUTCOMES Shabana kalla
125 OBSERVATIONAL STUDY ON PERITONEAL DIALYSATE FLUSH VOLUMES AND ITS IMPACT ON PERITONITIS EPISODES Chau Joey Lam
126 BLISTERING SKIN IN A PATIENT ON PERITONEAL DIALYSIS Stephanie Lam
127 THE ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES (PROMS) AND TRADITIONAL DIALYSIS ADEQUACY MEASURES IN PERITONEAL DIALYSIS (PD) PATIENTS Aruni Malaweera, Louis Huang, Lawrence McMahon
128 PERITONEAL DIALYSIS IN PATIENTS WITH TRANS-ABDOMINAL LINES: A CASE SERIES Sophie O’Brien, Kee Whye Chin
129 DIALYSATE POTASSIUM LOSS CONTRIBUTES TO HYPOKALEMIA IN PD PATIENTS Surjit Tarafdar
130 RETROSPECTIVE REVIEW OF CULTURE-NEGATIVE PERITONITIS AT WESTERN RENAL SERVICES Jadon Yang

QUALITY INDICATORS

131 RISK FACTORS FOR DELAYED OR OMITTED TACROLIMUS IN KIDNEY TRANSPLANT RECIPIENTS DURING HOSPITAL ADMISSIONS – A SINGLE CENTRE STUDY Gayathri Bimal
132 CLINICIAN COMPREHENSION OF QUALITY INDICATOR PRESENTATIONS IN KIDNEY FAILURE CARE Christopher Davies
133 CREATING A CONSUMER ADVISORY PANEL WITHIN THE AUSTRALIAN AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY – BUSINESS AS USUAL Jasmin Mazis
134 QUALITY INDICATORS AND KIDNEY SUPPORTIVE CARE Hannah Sawkins
135 IS THERE AN EDITORIAL GLASS CEILING? A GENDER-BASED CROSS-SECTIONAL ANALYSIS OF NEPHROLOGY AND TRANSPLANTATION JOURNALS. Rose-marie Scarlato
136 CONCEPTUALISING, OPERATIONALISING AND UTILISING EQUITY, DIVERSITY AND INCLUSION IN CLINICAL TRIALS: A SCOPING REVIEW Shiva Raj Mishra
137 ROUTINE EXCLUSIONS IN NEPHROLOGY CLINICAL TRIALS FROM 2010 TO 2023: A META EPIDEMIOLOGICAL STUDY Shiva Raj Mishra

TRANSPLANTATION

138 CHARACTERISING CARDIOVASCULAR RISK IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS – NEXT STEPS IN OPTIMISING CARE. Gheed Al Maraee
139 A CASE REPORT OF PROFOUND HYPERTRIGLYCERIDAEMIA (51 MMOL/L) FOLLOWING CHEMOTHERAPY FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN A KIDNEY TRANSPLANT RECIPIENT. Cameron Burnett
140 ONE DAY RENAL TRANSPLANT WORKUP PROGRAMME – A PATIENT-CENTRED, EQUITY FOCUSED QUALITY INITIATIVE Richard Germann
141 CASE STUDY: AN APPROACH TO TREATING A DIFFICULT RESISTANT CYTOMEGALOVIRUS INFECTION POST KIDNEY TRANSPLANT Neesan David
142 GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS DISEASE: THE TROLL OF TRANSPLANTATION Jeffrey Ha
143 RECURRENT TRANSPLANT RENAL ARTERY STENOSIS Stephanie Lam
144 KIDNEY TRANSPLANT REJECTION IN PEOPLE LIVING WITH HIV Lucy McMullen
145 SUCCESSFUL RENAL TRANSPLANTATION IN A PATIENT WITH ATYPICAL HAEMOLYTIC-URAEMIC SYNDROME FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT Sophie O’Briend
146 PHYSIOTHERAPY ASSESSMENT AND INTERVENTION OF FRAILTY IN KIDNEY TRANSPLANT WORK UP Erica Patterson
147 RARE CASE OF PARVOVIRUS INFECTION CAUSING PURE RED CELL APLASIA IN A KIDNEY-PANCREAS TRANSPLANT RECIPIENT Monica Ng
148 OBESITY AS A BARRIER TO TRANSPLANTATION: INSIGHTS FROM AN AUSTRALIAN TRANSPLANT CENTRE Kevan Polkinghorne
149 ASSOCIATION BETWEEN ESTIMATED GLOMERULAR FILTRATION RATES AT INITIATION OF DIALYSIS AND ALL-CAUSE MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS WITH A FAILING KIDNEY ALLOGRAFT Dharshana Sabanayagam
150 A GLOBAL SURVEY OF SELF-REPORTED CANCER SCREENING PRACTICES BY HEALTH PROFESSIONALS FOR KIDNEY TRANSPLANT CANDIDATES AND RECIPIENTS Nida Saleem
151 KAPOSI SARCOMA: A RARE CAUSE OF UNILATERAL FOOT PAIN IN A SOLID ORGAN TRANSPLANT RECIPIENT Siaw Wee Teo
152 HEALTH PROFESSIONAL EXPERIENCES OF KIDNEY TRANSPLANTATION IN AUSTRALIA Tara Watters
153 PATIENT PERSPECTIVES ON DECISION MAKING IN DECEASED DONOR KIDNEY TRANSPLANT OFFERS: A QUALITATIVE STUDY Alison Weightman
154 RESISTANT MYCOBACTERIUM AVIUM COMPLEX INFECTION – A DIAGNOSTIC MANAGEMENT CONUNDRUM IN A DIALYSIS DEPENDENT PATIENT FOLLOWING GRAFT FAILURE Pamela Wu

 

Categories